Eton Pharmaceuticals, Inc. (ETON)
24.99
-0.37
(-1.46%)
USD |
NASDAQ |
Apr 02, 16:00
24.97
-0.02
(-0.07%)
After-Hours: 20:00
Eton Pharmaceuticals Shareholders Equity (Quarterly) : 26.15M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Corcept Therapeutics, Inc. | 647.80M |
| Amicus Therapeutics, Inc. | 274.24M |
| Ovid Therapeutics, Inc. | 130.66M |
| Rhythm Pharmaceuticals, Inc. | 139.07M |
| Vir Biotechnology, Inc. | 765.28M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 92.11M |
| Total Liabilities (Quarterly) | 65.96M |
| Debt to Equity Ratio | 1.188 |
| Current Ratio | 1.574 |
| Net Debt Paydown Yield | -1.17% |